Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
Actual shortage: | 240 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2021-04-21 | 2021-05-20 | 137890 |
TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2021-04-21 | 2021-05-13 | 137893 |
TEVA-FLUOXETINE | 20MG | CAPSULE | Resolved | 2021-04-21 | 2021-06-03 | 137896 |
TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2021-04-21 | 2024-04-01 | 137899 |
TEVA-LOSARTAN | 100MG | TABLET | Resolved | 2021-04-21 | 2024-04-01 | 137902 |
ACT PIOGLITAZONE | 30MG | TABLET | Resolved | 2021-04-21 | 2022-04-28 | 137905 |
TEVA-VALSARTAN | 40MG | TABLET | Actual shortage | 2021-04-22 | 2021-04-22 | 137930 |
TEVA-VALSARTAN | 80MG | TABLET | Actual shortage | 2021-04-22 | 2024-01-08 | 137933 |
TEVA-VALSARTAN | 160MG | TABLET | Resolved | 2021-04-22 | 2023-06-09 | 137936 |
TEVA-VALSARTAN | 320MG | TABLET | Actual shortage | 2021-04-22 | 2021-04-22 | 137939 |
ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2021-04-29 | 2021-07-09 | 138282 |
TEVA-LENOLTEC NO. 2 | 15MG 15MG 300MG | TABLET | Resolved | 2021-04-29 | 2021-06-10 | 138285 |
TEVA-LENOLTEC NO. 3 | 300MG 30MG 15MG | TABLET | Resolved | 2021-04-29 | 2021-05-06 | 138288 |
TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Resolved | 2021-04-29 | 2021-08-07 | 138291 |
TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2021-04-29 | 2021-05-13 | 138294 |
TEVA-CYPROTERONE / ETHINYL ESTRADIOL | 0.035MG 2MG | TABLET | Resolved | 2021-04-29 | 2021-09-02 | 138297 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-04-29 | 2021-05-13 | 138300 |
TEVA-CAPTOPRIL | 50MG | TABLET | Resolved | 2021-04-29 | 2021-05-06 | 138303 |
TEVA-LOSARTAN | 25MG | TABLET | Resolved | 2021-04-29 | 2024-04-01 | 138306 |
TEVA-LOSARTAN | 50MG | TABLET | Resolved | 2021-04-29 | 2021-05-20 | 138309 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 10MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63975 |
TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63978 |
ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |